Aripiprazole

Aripiprazole

Products
Aripiprazole
Aripiprazole

Information

Therapeutic Area: Nervous SystemEU DMF availableUS DMF no. 23314 availableCEP available Indication: used to treat the symptoms of psychotic conditions such as schizophrenia and bipolar disorder (manic depression). It is also used together with other medications to treat major depressive disorder in adults. Aripirazole is also used to treat irritability and symptoms of aggression, mood swings, temper tantrums, and self-injury related to autistic disorder in children who are at least 6 years old.
Product Categories
  • Generic APIs
    Distribution Areas
    OceaniaNorth America (USA, Canada)Middle East Region (e.g. UAE)Central America (e.g. Mexico)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)
    Supplied From
    Poland
    Polpharma S.A.Polpharma Group. European business partner for pharmaceutical companies worldwide. Diversified business oportunities - API, CDMO, OL, In-licensing - supported by professional services and competencies dedicated to the B2B partners to grow beyond the scale together. We are offering environment for collaboration, support from qualified experts and state-of-the-art facilities. We are actively looking for partners in all of our activity areas - from product development stage, through production and commercial cooperation, to other forms of partnership. Polpharma API

    Log in

    See all the content and easy-to-use features by logging in or registering!